138 related articles for article (PubMed ID: 4051899)
1. Management of common forms of hyperlipidaemia.
Nestel PJ
Aust Fam Physician; 1985 Aug; 14(8):798, 800, 802. PubMed ID: 4051899
[No Abstract] [Full Text] [Related]
2. [Therapeutic orientation in the hyperlipidemias].
Forti N; Diament J; Giannini SD
Arq Bras Cardiol; 1979 Sep; 33(3):207-15. PubMed ID: 396911
[No Abstract] [Full Text] [Related]
3. Diagnosis and management of hyperlipidemia.
Palumbo PJ
Compr Ther; 1978 Oct; 4(10):33-9. PubMed ID: 359229
[No Abstract] [Full Text] [Related]
4. [Hyperlipemias : therapeutics (dietetics-medication)].
Benoit G
Lille Med; 1975 Apr; 20(4):381-6. PubMed ID: 1152590
[No Abstract] [Full Text] [Related]
5. Editorial: Is control of hyperlipidaemia important in renal diseases?
Med J Aust; 1974 Jul; 2(4):115-8. PubMed ID: 4608833
[No Abstract] [Full Text] [Related]
6. Managing hyperlipidaemia.
Nestel PJ
Med J Aust; 1988 Jan; 148(1):29-31. PubMed ID: 3336296
[No Abstract] [Full Text] [Related]
7. [Controversies and advances in the treatment of hyperlipidemias].
Reza-Albarrán A; Aguilar-Salinas CA
Gac Med Mex; 1998; 134(2):253-6. PubMed ID: 9619005
[No Abstract] [Full Text] [Related]
8. Management of dyslipidemia.
Akel MM; Salti I
J Med Liban; 2001; 49(5):274-8. PubMed ID: 12243421
[No Abstract] [Full Text] [Related]
9. NHF guidelines on the management of dyslipidaemia.
Mann J; Agnew T
N Z Med J; 1996 Sep; 109(1029):345. PubMed ID: 8862356
[No Abstract] [Full Text] [Related]
10. Some aspects of the management of the hyperlipidaemias.
Rowe WS
Med J Aust; 1975 May; 1(18):563-5. PubMed ID: 1143148
[No Abstract] [Full Text] [Related]
11. Hyperlipoproteinemia: diagnosis and management.
Shakir KM
Prim Care; 1976 Jun; 3(2):277-91. PubMed ID: 1047448
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of hyperlipidemia in patients with coronary heart disease].
Tikkanen MJ; Miettinen T
Duodecim; 1992; 108(19):1649-52. PubMed ID: 1366190
[No Abstract] [Full Text] [Related]
13. Dietary and pharmacologic therapy of the lipid risk factors. AMA Council on Scientific Affairs.
Conn Med; 1985 May; 49(5):321-8. PubMed ID: 3891221
[No Abstract] [Full Text] [Related]
14. Diagnosis and treatment of Type II and Type IV hyperlipoproteinemia in the office practice setting.
Millett F; Sielski J; Stoll H; Alston N; Gail S
PA J; 1976; 6(2):54-9. PubMed ID: 10235781
[No Abstract] [Full Text] [Related]
15. Management of hypercholesterolaemia in the patient with diabetes.
Packard C; Olsson AG
Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
[TBL] [Abstract][Full Text] [Related]
16. [Antilipemic drugs].
Schwandt P
Med Monatsschr Pharm; 1980 Oct; 3(10):302-5. PubMed ID: 7007844
[No Abstract] [Full Text] [Related]
17. Choosing the most appropriate therapy for lipid disorders.
Simons LA
Aust Fam Physician; 2000 Mar; 29(3):199-203. PubMed ID: 10785984
[TBL] [Abstract][Full Text] [Related]
18. Aggressive medical therapy for the prevention and treatment of coronary artery disease.
Malloy MJ; Kane JP
Dis Mon; 1998 Jan; 44(1):1-40. PubMed ID: 9457050
[No Abstract] [Full Text] [Related]
19. Modern management of hyperlipidemia.
Grundy SM
Compr Ther; 1984 Sep; 10(9):46-53. PubMed ID: 6091992
[No Abstract] [Full Text] [Related]
20. [Therapeutic trial of a normolipemic agent: ethanolamine N-oxy-nicotinate].
Warembourg H; Ketelers JY; Ginestet A
Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1331-5. PubMed ID: 4608970
[No Abstract] [Full Text] [Related]
[Next] [New Search]
